StreetAlpha
Crescent Biopharma, Inc. · 13F filings

CBIO Institutional Ownership

Holdings as of Sep 30, 2026From SEC Form 13FUpdated

Who owns Crescent Biopharma, Inc. and what the big funds did with it last quarter, from every SEC 13F filing. 106 funds reported holding CBIO at Sep 30, 2026, together owning 104.5% of the company.

← CBIO stock page

Who owns the most CBIO

% of company · value · change
  1. 1Fmr LLC15.18%$86.2M+1.8M
  2. 2Fairmount Funds Management LLC9.26%$52.5M+853K
  3. 3Bvf Inc/il7.95%$45.1M+345K
  4. 4Vestal Point Capital, LP7.71%$43.8M+1.4M
  5. 5BlackRock, Inc.5.50%$31.2M+866K
The top 5 own 45.6% of CBIO. Biggest move: Fmr bought 1.8M shares (+$25.8M).See all top holders ↓
Free account: all 25 CBIO holders, every new CBIO 13F filing as it lands, and each fund’s full portfolio. Create free accountSign in
AI Pro · stock alerts

Get an alert when the big funds move CBIO

13F season runs for 45 days after each quarter. We watch every filing and tell you the moment a superinvestor or one of CBIO’s top 25 holders buys, sells or exits (moves of 5% or more), by email or on your phone.

Stock alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

What an alert looks like
Logos Global Management cut CBIO by 1.1M sharesQ3 2026 13F · −$15.3M
Fmr added to CBIO by 1.8M sharesQ3 2026 13F · +$25.8M
Real CBIO moves from last quarter’s filings. Alerts come from public SEC 13F filings and are not investment advice.
Fund sentiment
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲81 buying vs 27 selling
  • ▲Held by funds +28.4 pts
  • ▲Funds holding +24
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful

What the filings show, not a forecast. Positions can be up to 45 days old and leave out short sales.

Funds holding106+24 vs Q2 2026
Held by funds104.5%+28.4 pts
Value held$593M40.6M shares
Put/call ratio0.00market makers left out

Funds holding and ownership

6 quarters
Q2 2025: 30 fundsQ2 '25Q3 2025: 41 fundsQ3 '25Q4 2025: 58 fundsQ4 '25Q1 2026: 63 fundsQ1 '26Q2 2026: 82 fundsQ2 '26Q3 2026: 106 fundsQ3 '26104.5% owned
Funds holdingHeld by funds %

Quarter over quarter

all 13F filers
Q3 2026This quarterQ2 2026Change
Funds holding10682+29.3%
In funds' top 10330.0%
13F shares40.6M29.6M+37.4%
Held by funds104.5%76.1%+28.4 pts
New positions3732+15.6%
Increased4417+158.8%
Reduced1315−13.3%
Sold out1413+7.7%
Calls (shares)300K0–
Puts (shares)00–
Put/call ratio0.00––

Buyers vs sellers

adding or new vs cutting or sold out
Q2 2025: 30 buyingQ2 2025: 0 sellingQ2 '25Q3 2025: 21 buyingQ3 2025: 13 sellingQ3 '25Q4 2025: 38 buyingQ4 2025: 14 sellingQ4 '25Q1 2026: 33 buyingQ1 2026: 20 sellingQ1 '26Q2 2026: 49 buyingQ2 2026: 28 sellingQ2 '26Q3 2026: 81 buyingQ3 2026: 27 sellingQ3 '26
Buying 81Selling 27latest quarter

Superinvestors in CBIO

All superinvestors →

Who owns CBIO

share of fund held shares
  • Index and passive funds14.4%
  • Active managers and hedge funds82.0%
  • Banks and brokers3.5%
  • Pensions, insurers and other0.0%

The top 10 holders own 65.0% of all CBIO shares that funds reported. Groups are our own grouping of filers by name.

Top holders

Q3 2026
#FundOf companySharesValueChange
1Fmr LLC15.18%5.9M$86.2M+1.8M
2Fairmount Funds Management LLC9.26%3.6M$52.5M+853K
3Bvf Inc/il7.95%3.1M$45.1M+345K
4Vestal Point Capital, LP7.71%3M$43.8M+1.4M
5BlackRock, Inc.5.50%2.1M$31.2M+866K
6Venrock Adviser, LLC5.49%2.1M$31.1M+158
7Fcpm III Services B.v.5.20%2M$29.5M+345K
8Opaleye Management Inc.4.23%1.6M$24M+327K
9Balyasny Asset Management L.P.4.14%1.6M$23.5M−51K
10Vanguard Capital Management LLC3.26%1.3M$18.5M+501K
🔒 15 more top holders. Create a free account or sign in to see them.
Biggest buyers
Biggest sellers

CBIO institutional ownership FAQ

Who owns the most CBIO stock?

In Q3 2026 13F filings the largest holder of CBIO was Fmr LLC, followed by Fairmount Funds Management LLC and Bvf Inc/il. Index fund managers are usually the biggest holders of large companies.

What percentage of CBIO is owned by institutions?

Funds that file 13F reports held 104.5% of CBIO's shares at Sep 30, 2026, compared with 76.1% a quarter earlier. That counts every manager with more than $100 million in US stocks.

Are hedge funds buying CBIO?

In Q3 2026, 81 funds bought CBIO (37 of them new positions) and 27 sold (14 sold out completely). Among well known investors, 2 added and 2 cut. Our fund sentiment for CBIO is bullish.

What is CBIO's institutional put/call ratio?

Funds reported $0 of CBIO puts against $4.4M of calls, a put/call ratio of 0.00. Market makers and bank trading desks are left out, since their options are mostly hedges.

How current is this CBIO ownership data?

13F filings show holdings at the end of each quarter and are due within 45 days, so positions can be up to six weeks old when they appear. We add each new filing within minutes, and the "filed so far" list shows funds that have already reported the next quarter.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Fund sentiment summarises what 13F filings show and is not a forecast. Holdings come from SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.